RankingsPricing
  1. JP-listed companies
  2. ZERIA PHARMCEUTICAL CO., LTD.
  3. Financials
  4. Net income

ZERIA PHARMCEUTICAL CO., LTD.【JP:4559】

Market cap
¥112.2B
P/E ratio
9.8x
SummaryFinancialsDividendsHistoryOwnershipWorkforce
Period EndNet income (Million JPY)YoY (%)
Mar 31, 20259,968+28.93%
Mar 31, 20247,731+24.56%
Mar 31, 20236,207+56.15%
Mar 31, 20223,975+26.93%
Mar 31, 20213,131+6.56%
Mar 31, 20202,939-15.16%
Mar 31, 20193,464-17.19%
Mar 31, 20184,183+16.98%
Mar 31, 20173,576+1.23%
Mar 31, 20163,532+38.11%
Mar 31, 20152,558-39.76%
Mar 31, 20144,246+20.74%
Mar 31, 20133,516+85.78%
Mar 31, 20121,893

Income Statement

RevenueRevenue growth (%)Cost of revenueGross profitGross margin (%)Research & developmentSelling, general & administrativeOperating margin (%)Operating income Operating expenses Income before tax Pretax margin (%)Provision for income taxesEffective tax rate (%)Net income Net income margin (%)Earnings per shareDiluted EPSAdjusted EPSDividend payout ratio (%)Dividend per shareAdjusted DPSEBITDAEBITDA margin (%)

Balance Sheet

Cash and cash equivalents Marketable securities, current Total cash & short-term investmentsAccounts receivable, netInventoriesTotal current assetsProperty, plant and equipment, netMarketable securities, non-current Total non-current assetsTotal assets Accounts payableShort-term debtLong-term debt, current Total current liabilitiesLong-term debt, non-current Total non-current liabilitiesTotal liabilities Common stock and paid-in capital Retained earningsStockholders' equityTotal debtNet debtD/E ratio (%)Working capital

Cash Flow

Depreciation & amortizationStock-based compensationCash from operations Capital expendituresCash from investing Payments for dividends Repurchases of common stockProceeds from issuance of term debt, netRepayments of term debtCash from financing Free cash flowFCF margin (%)